Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases

摘要

Background:There is limited data on the efficacy of anti-programmed death 1 (PD-1) antibodies in patients (pts) with melanoma brain metastasis (BM), particularly those which are symptomatic.